Illumina, Roche deal

Roche began an unsolicited tender offer to acquire sequencing and microarray company Illumina for $44.50 per share, or about $5.7 billion in cash. The offer will expire at midnight EST on Feb. 24. The price is an

Read the full 378 word article

How to gain access

Continue reading with a
two-week free trial.